产前母体血清游离DNA检测未能获得结果的影响:一项历史性队列研究
在澳大利亚悉尼一家多中心私立诊所开展的历史性队列研究,纳入131例无创产前检测(NIPT)未获结果的孕妇,比较其妊娠结局与同机构获得结果者及澳大利亚一般产科人群。未获结果者染色体非整倍体、子痫前期和妊娠期糖尿病发生率显著更高,PAPP-A和游离β-hCG降低、子宫动脉PI升高。
要点
- NIPT未获结果者染色体非整倍体率6.5%,显著高于一般产科人群的0.2%(P<0.0001)。
- NIPT未获结果者子痫前期率11% vs 1.5%、妊娠期糖尿病率23% vs 7.5%,均显著增高(P<0.0001)。
- NIPT未获结果者PAPP-A MoM降低(0.75 vs 1.14)、游离β-hCG降低(0.71 vs 1.01)、子宫动脉PI升高(1.79 vs 1.65)。
核心结论
- NIPT未获结果的孕妇不良妊娠结局风险增加,尤其是染色体非整倍体、妊娠期糖尿病和子痫前期。
研究设计与样本
- 历史性队列研究,纳入澳大利亚悉尼一家多中心私立诊所中NIPT未获结果的孕妇131例,比较其母体特征、产前检查及妊娠结局与同机构获得结果者及澳大利亚一般产科人群。
主要发现
- 仅1.1%的NIPT样本未返回结果;该队列较澳大利亚一般产科人群年龄显著更大且体重显著增加;94%的队列可获得妊娠结局。
- 与一般产科人群相比,染色体非整倍体率6.5% vs 0.2%(P<0.0001)、子痫前期率11% vs 1.5%(P<0.0001)、妊娠期糖尿病率23% vs 7.5%(P<0.0001)均显著更高。
- 早产和小于胎龄儿(SGA)发生率升高但未达统计学显著。
- 产前检查显示PAPP-A MoM降低(0.75 vs 1.14,P<0.0001)、游离β-hCG降低(0.71 vs 1.01,P<0.0001)、子宫动脉PI升高(1.79 vs 1.65,P=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the pregnancy outcomes in a cohort of women who failed to obtain a result in non-invasive prenatal testing (NIPT). DESIGN: Historical cohort study. SETTING: A multicentre private practice in Sydney, Australia. POPULATION: Women who failed to obtain a result from NIPT (n = 131). METHODS: The maternal characteristics, antenatal investigations and pregnancy outcomes for these women were compared with those who obtained a result at the same practice and to the general Australian obstetric population. MAIN OUTCOME MEASURES: Antenatal investigations: pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotrophin (β-hCG), placental growth factor (PlGF), uterine artery pulsatility index (PI), mean arterial pressure (MAP). Pregnancy outcomes: chromosomal abnormality, pre-eclampsia, gestational diabetes, small-for-gestational-age (SGA), preterm delivery. RESULTS: Only 1.1% of NIPT samples failed to return a result. This cohort was significantly older and had significantly increased weight compared with the general Australian obstetric population. Pregnancy outcomes were available for 94% of the cohort. There were significantly higher rates of chromosomal aneuploidies (6.5% versus 0.2%, P < 0.0001), pre-eclampsia (11% versus 1.5%, P < 0.0001) and gestational diabetes (23% versus 7.5%, P < 0.0001) compared with the general obstetric population. Rates of preterm delivery and SGA were elevated but did not reach significance. Antenatal investigations demonstrated decreased PAPP-A MoM (0.75 versus 1.14, P < 0.0001), decreased free β-hCG (0.71 versus 1.01, P < 0.0001) and increased uterine artery PI (1.79 versus 1.65, P = 0.02). CONCLUSION: Women who fail to obtain a result from NIPT are at increased risk of adverse pregnancy outcomes, in particular chromosomal aneuploidy, gestational diabetes and pre-eclampsia. FUNDING: None received. TWEETABLE ABSTRACT: Women who fail to obtain a result from cell-free DNA NIPT are at increased risk of adverse pregnancy outcomes.
引用
- Chan N, Smet ME, Sandow R, et al. Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study. BJOG. 2017. PMID: 29090507. doi:10.1111/1471-0528.15006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。